• Harbin Clinic Clinical Research
  “Since 1997, Harbin Clinic’s team of research doctors and nurses have been providing a wide range of clinical trials services in support of researchers in the pharmaceutical and device industries. The Harbin Clinic enrolls hundreds of patients in clinical trials across a broad range of diagnoses including rheumatoid arthritis, osteoarthritis, diabetes, cardiology, heart catheterization trials, irritable bowel syndrome, migraine, hypertension, cancer, and many others.”

• Molecular Genetic Resources
  “MGR offers DNA/RNA Modifying Enzymes, DNA/RNA Purification Kits, Molecular Weight Markers, Polymerases, and Specialty Reagents. Our products are used worldwide in academic, commercial, and government laboratories in a diverse range of applications that include microbiology, cancer and infectious disease research, drug discovery, clinical and basic molecular biology research.”

• Northwest Georgia Cancer Coalition
  The mission of the Northwest Georgia Regional Cancer Coalition is to reduce the number of cancer deaths and the mortality rate from cancer in Northwest Georgia. This mission is accomplished through several goals, including: 1) Prevent cancer and detect existing cancers earlier.The initiative works to reduce the number of cancer deaths through a focused education and screening effort. 2) Improve access to quality care for all NW Georgians with cancer.The NWGRCC wants to ensure that basic cancer care is available close to home anywhere in the state. More advances treatment will be available at medical centers in regional service areas, enabling NW Georgians to get quality medical care and participate in clinical trials without leaving the state. 3) Save more lives in the future.Through work with medical schools and community oncologists, a mechanism will be put in place to extend and coordinate clinical trials. 4) Train future cancer researchers and caregivers.The NWGRCC supports using nationally recognized standards for training of future cancer clinicians and development of new training programs for cancer caregivers. 5) Realize economic benefits from eradicating cancer.Investment in research, expanded capacity and partnerships with pharmaceutical and biotechnology companies will provide quality jobs to NW Georgians and environmentally clean additions to the economy. Private funding will help support research and launch new developments with commercial potential.

• Prism Research Group
  “Prism Research Group is a dedicated clinical research facility located in the heart of Rome, GA central to Atlanta, GA and Chattanooga, TN with a surrounding population of greater than half-a-million. Prism conducts Phase I-IV multi-specialty pharmaceutical research. Prism ensures the highest patient safety by providing an exceptional level of care and attention to potential research subjects.  By collaborating with local physicians and healthcare providers we are able to provide a wide range of medical specialties for potential pharmaceutical research companies. Our dedicated staff works together as a team to provide high-quality comprehensive care to our participants and accurate sound data for advancement of medicine through research. Our research specialties include, but are not limited to: Alzheimer's, Cardiology, Diabetes, Fibromyalgia, Gastroenterology, Migraine Headache, Parkinson's Disease, Pain Disorders, Sleep disorders, Ophthalmology, Psychology, and Neurology. Pharmaceutical/CRO companies we currently or have previously conducted clinical research: Alcon, Bausch & Lomb, Astra Zeneca, PPD, Merck Pharmaceuticals, Johnson & Johnson, Mapi Vaules, Quintiles, ICON, Sanofi Aventis, Phase Forward, Furiex Pharmaceuticals, and Chelsea Therapeutics.”

• Sarah Cannon Research Institute
  Clinical trials in Rome, Georgia are completed in partnership with Redmond Regional Medical Center and the Harbin Clinic. Trials include over six years of clinical research experience in indications including: Coronary Artery Syndrome, Acute MI, Coronary Artery Lesions, Vein Grafts, and Percutaneous Coronary Interventions. There are seven primary investigators who serve as sub-investigators on each other’s trials. The practice is capable of performing: nuclear scans, EKGs, echocardiograms, vascular ultrasounds, Venous Doppler, treadmill studies, pacemaker/ICD evaluations Experience in Percutaneous Coronary Interventional clinical trials and EP trials. There are approximately 1,000 new patients seen per year. Demographics are 86% Caucasian,  11% African American, and 1.3% Hispanic.